Syngenta, headquartered in Basel, Switzerland is a leading developer, manufacturer and supplier of crop protection chemicals and high-value seeds to growers around the world. The Group is listed on the Swiss and New York stock exchanges, operates in approximately 90 countries, and has 27,000 employees, with annual sales of over USD14 billion. It was formed in 2000, following the merger of the agribusiness divisions of Novartis and AstraZeneca.
"After being heavily involved in the formation of Syngenta, and acting as joint auditor briefly, the recommendation as global auditor was forged by a determination over many years to remain relevant to the key challenges faced by Syngenta across the world" said Chris Stirling, Chair of KPMG's Global Life Sciences practice. "Having provided tax and advisory services to Syngenta in many parts of the world, such as Latin America where the Group has enjoyed significant and sustained growth, KPMG professionals were able to articulate a compelling audit proposition.
Confidence and culture also played a major role in the selection of KPMG. Beyond a thorough understanding of Syngenta's business and our reputation for audit quailty, the visibility of KPMG partners in Switzerland and the UK stood out in the choice of global auditor.